CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Syncona (SYNC) is a large British closed-ended investment fund targeting healthcare and life science investments. The company focuses on equity, hedge, and long-term alternative investment funds across various asset classes in the markets worldwide. It manages fixed income, debt, private equity, and alternative investments. It operates in two segments: life science portfolio and fund investments. The company makes its life science investments through Syncona Holdings Limited and its fund investments through Syncona Investments LP Incorporated. The Syncona share price is listed on the London Stock Exchange and included in the FTSE 250 Index.
You can find the latest SYNC share price at Capital.com.
The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.
14:43, 2 February 2024
Read our reviews to find out more about us
Read the feedback from our clients, whatever their experience level.
Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.